Insiders · PVLA

PVLA insider transactions

Palvella Therapeutics Inc. (PVLA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PVLA

• 17d
  Chief Operating Officer Goin Kathleen exercised 4,302 shares at a strike of $8.11 and sold $475,631 worth of shares (4,302 units at $110.56) as part of a pre-agreed trading plan (SEC Form 4)

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 52d
  SEC Form 4 filed by Goin Kathleen

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 54d
  SEC Form 3 filed by new insider Doux John

  3 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 54d
  SEC Form 4 filed by Doux John

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 68d
  SEC Form 4 filed by Jenkins George M

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 80d
  SEC Form 4 filed by Goin Kathleen

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 99d
  Director Jenkins George M bought $500,000 worth of shares (4,000 units at $125.00), increasing direct ownership by 2% to 187,171 units (SEC Form 4)

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 99d
  Director Heron Elaine J bought $300,000 worth of shares (2,400 units at $125.00), increasing direct ownership by 5% to 47,812 units (SEC Form 4)

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 108d
  Chief Operating Officer Goin Kathleen exercised 4,302 shares at a strike of $8.11 and sold $341,564 worth of shares (4,302 units at $79.40) (SEC Form 4)

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 119d
  SEC Form 4 filed by Chief Scientific Officer Martini Jeffrey S

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 119d
  SEC Form 4 filed by Chief Commercial Officer Kline Ashley Hartmann

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 119d
  SEC Form 4 filed by President and CEO Kaupinen Wes

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 119d
  SEC Form 4 filed by CFO, Treasurer Korenberg Matthew E

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 119d
  SEC Form 4 filed by Chief Operating Officer Goin Kathleen

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 136d
  Chief Operating Officer Goin Kathleen sold $419,983 worth of shares (4,302 units at $97.63) and exercised 4,302 shares at a strike of $8.11 (SEC Form 4)

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 171d
  Chief Operating Officer Goin Kathleen exercised 4,302 shares at a strike of $8.11 and sold $415,023 worth of shares (4,302 units at $96.47) (SEC Form 4)

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 199d
  Chief Operating Officer Goin Kathleen exercised 4,302 shares at a strike of $8.11 and sold $370,965 worth of shares (4,302 units at $86.23) (SEC Form 4)

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 362d
  SEC Form 4 filed by Director Wessel Tadd S.

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 362d
  SEC Form 4 filed by Director Kiritsy Christopher P

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 362d
  SEC Form 4 filed by Director Jenkins George M

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 362d
  SEC Form 4 filed by Director Heron Elaine J

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 362d
  SEC Form 4 filed by Director Davis Todd C

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 370d
  SEC Form 4 filed by Chief Commercial Officer Kline Ashley Hartmann

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 370d
  SEC Form 3 filed by new insider Kline Ashley Hartmann

  3 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 424d
  Director Jenkins George M bought $100,797 worth of shares (4,990 units at $20.20), increasing direct ownership by 1% to 183,171 units (SEC Form 4)

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 483d
  Amendment: SEC Form 4 filed by President and CEO Kaupinen Wes

  4/A - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 483d
  Amendment: SEC Form 4 filed by Chief Scientific Officer Martini Jeffrey S

  4/A - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 483d
  Amendment: SEC Form 4 filed by Chief Operating Officer Goin Kathleen

  4/A - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 483d
  Amendment: SEC Form 4 filed by CFO and Treasurer Korenberg Matthew E

  4/A - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 486d
  SEC Form 4 filed by Chief Scientific Officer Palvella Therapeutics, Inc.

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Reporting)
• 486d
  SEC Form 4 filed by CFO and Treasurer Palvella Therapeutics, Inc.

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Reporting)
• 486d
  SEC Form 4 filed by President and CEO Palvella Therapeutics, Inc.

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Reporting)
• 486d
  SEC Form 4 filed by Chief Operating Officer Palvella Therapeutics, Inc.

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Reporting)
• 518d
  Amendment: New insider Kaupinen Wes claimed ownership of 44,410 shares (SEC Form 3)

  3/A - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)
• 537d
  Director Jenkins George M bought $51,720 worth of shares (4,000 units at $12.93), increasing direct ownership by 2% to 180,671 units (SEC Form 4)

  4 - PALVELLA THERAPEUTICS, INC. (0001583648) (Issuer)